Depakote is not a controlled substance. It does not appear on the DEA’s list of scheduled drugs, which means it is not classified alongside medications with recognized potential for abuse or dependence, such as opioids, stimulants, or benzodiazepines. Despite being a serious prescription medication with important safety considerations, Depakote can be prescribed and refilled with fewer regulatory restrictions than controlled substances.
Why Depakote Is Not Scheduled
The DEA places drugs on its controlled substances schedules (I through V) based on their potential for abuse, physical dependence, and whether they produce a “high” or euphoric effect. Depakote, the brand name for divalproex sodium, does not have these properties. It works by boosting levels of a calming brain chemical called GABA and dampening overactive nerve signaling, but this mechanism does not produce the rewarding sensation that drives misuse of drugs like benzodiazepines or opioids.
In fact, Depakote is sometimes used in clinical settings to help reduce the need for benzodiazepines during alcohol withdrawal. In one study, patients given divalproex sodium required significantly less benzodiazepine medication, with a median dose of zero compared to 5.5 mg in the group that did not receive it. This highlights how differently Depakote behaves from drugs that carry abuse risk.
What This Means for Prescriptions and Refills
Because Depakote is not scheduled, filling and refilling it is simpler than with controlled substances. Your doctor can write a standard prescription with refills, and you are not subject to the federal rules that limit Schedule III and IV drugs to five refills within six months of the original prescription date. You also won’t need a new prescription each time, as is required for Schedule II drugs like certain stimulants and opioids.
Pharmacies can transfer Depakote prescriptions between locations without the one-time transfer limitation that applies to controlled substances. In practical terms, this means fewer trips to the doctor’s office and more flexibility at the pharmacy.
It Still Requires Monitoring
Not being a controlled substance does not mean Depakote is a casual medication. It carries three FDA boxed warnings, the most serious safety label a drug can receive.
- Liver damage: Fatal liver failure has occurred in patients taking Depakote, most often during the first six months of treatment. Children under two years old are at the highest risk. Doctors typically order liver function blood tests before starting treatment and at regular intervals afterward, especially early on. Warning signs include unusual fatigue, weakness, facial swelling, loss of appetite, and vomiting.
- Harm to a developing fetus: Depakote can cause serious birth defects, particularly neural tube defects like spina bifida, as well as lower IQ scores in children exposed during pregnancy.
- Pancreatitis: Life-threatening inflammation of the pancreas, including fatal cases, has been reported.
Doctors also monitor blood levels of the drug to keep it within the therapeutic range of 50 to 100 mcg/mL. Below that range, it may not be effective. Above it, the risk of side effects climbs.
What Depakote Is Used For
Depakote is FDA-approved to treat epilepsy (seizure disorders), manic episodes associated with bipolar disorder, and migraine prevention. It is available in standard and extended-release formulations. The extended-release version, Depakote ER, is designed for once-daily dosing.
Common Side Effects
The most frequently reported side effects are nausea, vomiting, abdominal pain, and diarrhea. Many people also experience headaches, drowsiness, or tremor (an uncontrollable shaking, often in the hands). Weight changes and shifts in appetite are common enough that doctors often discuss them before starting treatment. Hair loss, trouble sleeping, blurred or double vision, and difficulty with coordination can also occur. These side effects are often most noticeable when starting the medication or after a dose increase, and some improve over time as your body adjusts.